273O nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2- metastatic breast cancer

Autor: Hamilton, E.P., Cortés, J., Ozyilkan, O., Chen, S-C., Petrakova, K., Manikhas, A., Jerusalem, G., Hegg, R., Huober, J., Chapman, S.C., Yang, Z., Chen, Y., Johnston, E.L., Martin, M.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S348-S348
Databáze: ScienceDirect